Skip to main content

A Phase III, Randomized, Double-blind, Placebo-controlled, Efficacy, and Safety Study of Balovaptan in Adults with Autism Spectrum Disorder with a 2-year Open-Label Extension

Medication Clinical Trials


Please see attached flyer for further details about this study.


Evdokia Anagnostou, MDMelanie Penner MD FRCP(C)


Interested in participating

Please note that recruitment is closed at this time. To learn more about this study, you can also contact our study coordinator, Rianne Hastie Adams at email: or telephone: 416-425-6220, x6515.

Funding Agency

F. Hoffman-La Roche.

Download Flyer

Learn more about this study